Acorah Software Products - Accounts Production16.5.460falsetrue30 September 202328 September 2022falsetrueNo description of principal activity1 October 202330 September 202430 September 202414383736Olukayode Durodolaiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure143837362023-09-30143837362024-09-30143837362023-10-012024-09-3014383736frs-bus:PrivateLimitedCompanyLtd2023-10-012024-09-3014383736frs-bus:FilletedAccounts2023-10-012024-09-3014383736frs-bus:Micro-entities2023-10-012024-09-3014383736frs-bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3014383736frs-bus:Director12023-10-012024-09-30143837362022-09-27143837362023-09-30143837362022-09-282023-09-30
Registered number: 14383736
Herolinks Limited
Unaudited Financial Statements
For The Year Ended 30 September 2024
Herolinks Limited
Balance Sheet
As At 30 September 2024
Balance Sheet
Registered number: 14383736
2024
2023
£
£
Current assets
9,075
1
NET CURRENT ASSETS
9,075
1
TOTAL ASSETS LESS CURRENT LIABILITIES
9,075
1
Accruals and deferred income
(299)
-
NET ASSETS
8,776
1
CAPITAL AND RESERVES
8,776
1
Notes
1.General Information
Herolinks Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14383736. The registered office is 15 Tommy Johnson Walk, Manchester, M14 4JA.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
11
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.